XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' DEFICIT (Details) - Warrant [Member] - $ / shares
9 Months Ended 12 Months Ended 24 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance 22,327,894 37,241,694 37,241,694  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance $ 0.038 $ 0.036 $ 0.036  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms 1 year 1 month 28 days 2 years 7 days 1 year 10 months 2 days 1 year 7 months 28 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period (3,660,817) (7,458,303)    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 0.036 $ 0.03    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period   (3,333,333)    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value   $ 0.045    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance 18,667,077 26,450,058 22,327,894 22,327,894
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance $ 0.032 $ 0.037 $ 0.038 $ 0.038